When it comes to retinal health

They have been there all along—powering the cells, sustaining retinal health.
And as they begin to fade, so does everything that depends on them.

Learn More about the Role of Mitochondria in Dry AMD by Watching the Video Below.

Here are some of the facts

  • Dry age-related macular degeneration, or dry AMD, the leading cause of blindness among older adults in the developed world, is characterized by symptoms such as distorted vision, reduction in low luminance visual acuity, reduced overall visual acuity, and blurred vision

  • It is estimated that dry AMD impacts more than 10 million individuals in the United States

  • Mitochondrial dysfunction is believed to be a significant contributor to the progression of dry AMD, making the mitochondrial network an attractive target to improve retinal function and mitigate disease burdens in this patient population

  • There are no FDA or EMA approved treatments for the treatment of dry AMD

References: 1. Brown, Lewin, and Ash; Retinal Degenerative Diseases, Advances in Experimental Medicine and Biology 891, https://doi.org/10.1007/978-3-319-75402-4_2 2. Ratnapriya R, Chew EY. Age-related macular degeneration-clinical review and genetics update. Clin Genet. 2013;84(2):160-6 3. Hernández-Zimbrón LF, Zamora-Alvarado R, Ochoa-De la Paz L, Velez-Montoya R, Zenteno E, Gulias-Cañizo R, et al. Age-related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev. 2018;2018:8374647 4. Congdon N, O’Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Opthalmol. 2004;122(4):477-85.